INDUSTRY NEWS

01.002 RWE KR JULY 2022 E 02-08-2022

Real-world data is an invaluable supplement to randomised control trials

  • An article was published recently in the Journal of Clinical Pathways, titled “Real-World Data Will Continue to Provide Real Value to the Drug Development and Commercialization Process”
  • It affirmed that while randomised controlled trials provide the necessary information on drug safety and efficacy, they are often not generalisable to the real-world population; but real-world information can supplement this data gap
  • The paper proposes that real-world evidence may become vital to the drug development landscape as it allows for “creative and nimble” data collection and analysis that can provide the information demanded by precision medicine and/or small patient populations
Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.

About DISTILL

DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit www.svmpharma.com and contact us at enquiry@svmpharma.com

Ref: RWEJUL2022KRE